C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems

Patents for C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems (27,676)
11/2011
11/03/2011	US20110269741 Novel compositions and methods of use
11/03/2011	US20110269705 Quinolone compound and pharmaceutical composition
11/03/2011	US20110265878 Dye comprising a chromophore to which an acyloin group is attached
11/02/2011	EP2383260A2 Process for the preparation of statins
11/02/2011	EP2382193A1 Ppar agonist compositions and methods of use
11/02/2011	EP2381779A1 Selective inhibitors of akt and methods of using same
11/02/2011	EP2178841B1 Process and intermediate for the production of a tertiary alcohol as an intermediate in the synthesis of montelukast
11/02/2011	EP2013183B1 Derivatives of 4-(2-amino-1-hydroxiethyl)phenol as agonists of the beta2 adrenergic receptor
11/02/2011	CN102232067A Nicotinamide derivatives
11/02/2011	CN102229564A 4-(7-chlorine-4aminoquinoline)-5,6,7,8-tetrahydro-alpha-naphthol derivatives, preparation method and application thereof
11/02/2011	CN102229563A 4-amino quinoline derivative, preparation method and application thereof
11/02/2011	CN102229562A Novel 1-2-dihydroquinoline derivative having glucocorticoid receptor binding activity
11/02/2011	CN102229561A Method for preparing 2, 2-disubstituted 1, 2-dihydro quinoline derivative
11/01/2011	USRE42889 α- and β- amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
11/01/2011	US8049014 Aminoquinoline derivatives, preparation method thereof and pharmaceutical composition comprising the same
11/01/2011	US8048894 Quinolones and azaquinolones that inhibit prolyl hydroxylase
11/01/2011	CA2531911C Specific glucocorticosteroid having an anti-inflammatory activity
11/01/2011	CA2476586C Sulfonyl-derivatives as novel inhibitors of histone deacetylase
11/01/2011	CA2409741C Tnf-.alpha. production inhibitors
10/2011
10/27/2011	WO2011133728A2 Anti-viral compounds
10/27/2011	WO2011133659A2 Inhibitors of hif and angiogenesis
10/27/2011	WO2011132712A1 Novel hydroxamic acid derivative
10/27/2011	WO2011131135A1 Heteroaryl (alkyl) dithiocarbamate compounds, preparation methods and uses thereof
10/27/2011	US20110263861 Quinoline compound
10/27/2011	US20110263860 Preparation methods of 6-substituted amino-3-cyanoquinoline compounds and the intermediates thereof
10/27/2011	US20110263849 Method for rapidly methylating heteroaromatic arene and method for producing tracer for use in pet
10/27/2011	US20110263645 Compositions and Methods of Treating Retinal Disease
10/27/2011	US20110263614 Novel compounds
10/27/2011	US20110263564 Pyridine, bicyclic pyridine and related analogs as sirtuin modulators
10/27/2011	US20110263556 New Compounds
10/26/2011	EP2380898A1 Process to make glucocortisoid compounds
10/26/2011	EP2379505A1 Modified chloroquines with single ring moiety or fused ring moiety
10/26/2011	EP2379504A2 Coumarin-based compounds
10/26/2011	EP2379076A1 Phosphodiesterase inhibitors and uses thereof
10/26/2011	EP2037739B1 Benzyl-substituted quinolone m1 receptor positive allosteric modulators
10/26/2011	CN102225911A Preparation method for (E)-4<,>-(2-quinoline-2-vinyl)-biphenyl-4-formaldehyde
10/26/2011	CN101817818B Compound used for preparing montelukast sodium
10/26/2011	CN101195614B Production of balofloxacin and purification process thereof
10/26/2011	CN101070304B Quinoline derivatives and their use as mycrobacterial inhibitors
10/20/2011	WO2011128251A1 Novel 3,3-dimethyl tetrahydroquinoline derivatives
10/20/2011	US20110257151 Novel 3,3-dimethyl tetrahydroquinoline derivatives
10/20/2011	CA2795387A1 Novel 3,3-dimethyl tetrahydroquinoline derivatives
10/19/2011	EP2376495A2 Compositions of protein receptor tyrosine kinase inhibitors
10/19/2011	EP2376477A2 Stereoselective synthesis of piperidine derivatives
10/19/2011	EP2376456A2 Highly pure laquinimod or a pharmaceutically acceptable salt thereof
10/19/2011	EP1648870B1 Sulfonic acid derivatives of polycyclic dyes used for analytical applications
10/19/2011	EP1613598B1 Methods of preparing aripiprazole crystalline forms
10/19/2011	CN102224217A Electroluminescent device using the electroluminescent compounds
10/19/2011	CN102224141A Solid forms of n-(4-(7-azabicyclo[2.2.1]heptan-7-yl)-2-(trifluoromethyl)phenyl)-4-oxo-5-(trifluoromethyl)-1,4-dihydroquinoline-3-carboxamide
10/19/2011	CN102224140A Curable composition comprising a thermolatent base
10/19/2011	CN102219736A Preparation method for 8-quinolinecarboxylic ester and 8-quinolinecarboxylic acid
10/19/2011	CN102219638A Fluorination method of vinyl carboxylic acid
10/19/2011	CN101429160B Synthesis method of 1-R-4-amino-1,2,3,4-tetrahydroquinoline
10/18/2011	US8039628 Isolation from mixture of stereoisomers; optical resolution of enantiomorphs
10/18/2011	US8039621 Process for preparing anhydrous Aripirazole type I
10/18/2011	US8039486 Viricides, immunomodulators or HIV entry inhibitors; lymphadenopathy associated virus, human T-cell leukemia/lymphoma virus; AIDS
10/18/2011	US8039467 Compounds for the treatment of inflammatory disorders
10/18/2011	CA2508341C Processes for preparing quinolonecarboxylate derivatives
10/18/2011	CA2443950C Inhibition of raf kinase using quinolyl, isoquinolyl or pyridyl ureas
10/13/2011	US20110251237 2,5-Disubstituted Piperidine Orexin Receptor Antagonists
10/13/2011	US20110251234 Mesylate salt of 5-(2--1-hydroxyethyl)-8-hydroxyquinolin-2(1h)-one as agonist of the beta2 adrenergic receptor
10/13/2011	US20110251209 Compounds for treating parasitic disease
10/13/2011	US20110251180 Pharmaceutical agent comprising quinolone compound
10/13/2011	US20110251165 Derivatives of 4-(2-amino-1-hydroxyethyl)phenol as agonists of the beta2 adrenergic receptor
10/12/2011	EP2374795A1 Sulphonic acid derivatives of polycyclic dyes used for analytical applications
10/12/2011	EP2231613B1 Montelukast benzhydryl piperazine salts and process for preparation thereof
10/12/2011	EP2107052B1 Novel n-(2-aminophenyl)benzamide derivative having an urea structure
10/12/2011	EP1385820B1 Anthranilic acid amides, method for the production thereof, their use as antiarrhythmia agents, and pharmaceutical preparations thereof
10/12/2011	CN102216321A Therapeutic antiviral peptides
10/12/2011	CN102212062A Derivative of amino ester, salt thereof and using method
10/12/2011	CN102212032A 5-hyroxyquinolone derivatives, and preparation method and application thereof
10/12/2011	CN101851195B Quinoline compound and synthetic method and application thereof in synthesizing camptothecin alkaloid
10/12/2011	CN101555225B Method for preparing poly-substituted quinoline compound
10/12/2011	CN101146808B Phenyl methanone derivatives and their use as glycine transporter 1 inhibitors
10/11/2011	US8034945 4-phenyl-5-OXO-1,4,5,6,7,8-hexahydroquinoline derivatives as medicaments for the treatment of infertility
10/11/2011	US8034944 Benzofluoranthene compound and organic light-emitting device using the compound
10/11/2011	US8034943 6-aminoisoquinoline compounds
10/11/2011	US8034810 Matrix metalloproteinase inhibitors; antiinflammatory agengs; rheumatoid arthritis, osteoarthritis; antitumor, anticarcinogenic, and antimetastasis agents; respiratory system disorders, chronic obstructive pulmonary disease, deblocking, deprotecting
10/11/2011	CA2368768C Preparation of quinoline-substituted carbonate and carbamate derivatives
10/06/2011	WO2011121091A1 Efficient synthesis for the preparation of montelukast and novel crystalline form of intermediates therein
10/06/2011	US20110245503 Enantioselective synthesis of asymmetric beta-carboline intermediates
10/06/2011	US20110245493 Delivery of drug amines through an inhalation route
10/06/2011	US20110245375 Curable composition comprising a thermolatent base
10/06/2011	US20110245353 Sweet flavor modifier
10/06/2011	CA2792068A1 Sweet flavor modifier
10/05/2011	EP2371820A1 Optically active cyclic alcohol compound and method for preparing the same
10/05/2011	EP2371819A1 New quinoline derivatives, a method for the production and the use thereof for treating microbacterial infections and a pharmaceutical composition based on said derivatives
10/05/2011	EP2370411A2 Compounds having antiparasitic or anti-infectious activity
10/05/2011	EP2370406A1 High penetration compositions and their applications
10/05/2011	CN1845933B Specific glucocorticosteriod compound having anti-inflamatory activity
10/05/2011	CN102206180A Substituted 6-cyclohexylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(ADP-ribose) polymerase inhibitors
10/05/2011	CN101792416B Process for preparing bosutinib
10/04/2011	US8030333 Benzimidazole compound crystal
10/04/2011	US8029767 Fluorescent membrane intercalating probes and methods for their use
10/04/2011	CA2673098C Method of preparing montelukast and intermediates used therein
10/04/2011	CA2434773C Piperazinylcarbonylquinolines and -isoquinolines
09/2011
09/29/2011	US20110237798 Direct conversion of phenols into amides and esters of benzoic acid
09/29/2011	US20110237792 Quinoline derivatives and their use as 5-ht6 ligands
09/29/2011	US20110237783 Hydrazonopyrazole derivatives and their use as therapeutics
09/29/2011	US20110237776 Aromatic compounds with sulfur containing ligands

1 ... 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 ... 277